cholestyramine resin has been researched along with Cardiovascular Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alderson, P; Lewis, SR; Nicholson, A; Sanders, RD; Smith, AF | 1 |
| Sjölander, A | 1 |
| Devendra, GP; Krasuski, RA; Whitney, EJ | 1 |
| Jacobson, TA | 1 |
| Abad, L; Aller, R; de Luis, DA; Dueñas, A; González-Sagrado, M | 1 |
| Balbisi, EA | 1 |
| Gutzwiller, F | 1 |
| Buyse, M; Geys, H; Molenberghs, G | 1 |
| Briedigkeit, W; Richter, H | 1 |
| Laupacis, A; Roberts, RS; Sackett, DL | 1 |
| Levy, RI | 1 |
| Fallat, RW; Glueck, CJ; Tsang, R | 1 |
| Schwandt, P | 1 |
6 review(s) available for cholestyramine resin and Cardiovascular Diseases
| Article | Year |
|---|---|
Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.
Topics: Adult; Angioplasty; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Cause of Death; Cholestyramine Resin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Perioperative Care; Postoperative Complications; Pyrroles; Randomized Controlled Trials as Topic; Sitosterols; Vascular Surgical Procedures | 2013 |
Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk.
Topics: Apolipoproteins B; Bile Acids and Salts; Cardiovascular Diseases; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Randomized Controlled Trials as Topic; Risk Assessment | 2011 |
[Levothyroxine poisoning: clinical manifestations and therapeutic management].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Cardiovascular Diseases; Child; Cholestyramine Resin; Gastrointestinal Diseases; Humans; Nervous System Diseases; Poisoning; Propranolol; Thyroid Hormones; Thyrotropin; Thyroxine | 2004 |
Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
Topics: Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Cholestyramine Resin; Clofibric Acid; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Life Style; Niacin; Risk Factors | 2006 |
[Primary prevention during childhood of adult cardiovascular diseases].
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Heterozygote; Homozygote; Humans; Hypertension; Infant; Middle Aged; Nutritional Physiological Phenomena; Obesity; Physical Exertion; Risk | 1978 |
Hypercholesterolemia and hypertriglyceridemia in children. A pediatric approach to primary atherosclerosis prevention.
Topics: Arteriosclerosis; Cardiovascular Diseases; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Economics; Fats; Fatty Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1974 |
3 trial(s) available for cholestyramine resin and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of increases in high-density lipoprotein cholesterol on cardiovascular outcomes during the armed forces regression study.
Topics: Adult; Aged; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Cholestyramine Resin; Coronary Artery Disease; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Lipoproteins, HDL; Male; Middle Aged; Niacin; Risk; Risk Factors; Treatment Outcome; Young Adult | 2010 |
[The National Research Program 1A: a community-oriented intervention study. Methodological considerations on various types of studies].
Topics: Cardiovascular Diseases; Cholestyramine Resin; Clinical Trials as Topic; Drug Evaluation; Ethics, Medical; National Health Programs; Population Surveillance; Research Design; Risk; Switzerland | 1980 |
Cholesterol and cardiovascular disease: no longer whether, but rather when, in whom, and how?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Random Allocation; Reference Values | 1985 |
4 other study(ies) available for cholestyramine resin and Cardiovascular Diseases
| Article | Year |
|---|---|
Bounds on natural direct effects in the presence of confounded intermediate variables.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Causality; Cholesterol; Cholestyramine Resin; Confidence Intervals; Confounding Factors, Epidemiologic; Effect Modifier, Epidemiologic; Humans; Hyperlipidemias; Programming, Linear; Random Allocation; Risk Factors; Smoking | 2009 |
Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes.
Topics: Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cholesterol; Cholestyramine Resin; Humans; Interferon-alpha; Macular Degeneration; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reproducibility of Results; Statistics as Topic; Treatment Outcome; Visual Acuity | 2001 |
Therapeutic priorities of Canadian internists.
Topics: Attitude of Health Personnel; Canada; Cardiovascular Diseases; Cholestyramine Resin; Humans; Hypercholesterolemia; Internal Medicine; Isoniazid; Tuberculosis | 1990 |
[Hyperlipoproteinemias: significance--diagnosis--therapy].
Topics: Adolescent; Adult; Blood Protein Disorders; Cardiovascular Diseases; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Diet Therapy; Diet, Reducing; Germany, West; Humans; Hyperlipidemias; Infant; Infant, Newborn; Lipoproteins; Middle Aged; Nicotinic Acids; Physical Exertion; Thyroxine; Triglycerides | 1971 |